# Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome

> **NCT02535611** · PHASE3 · COMPLETED · sponsor: **Mazandaran University of Medical Sciences** · enrollment: 47 (actual)

## Conditions studied

- Ischemic Stroke
- Excitotoxicity
- Memantine

## Interventions

- **DRUG:** Placebo
- **DRUG:** Memantine

## Key facts

- **NCT ID:** NCT02535611
- **Lead sponsor:** Mazandaran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-10
- **Final completion:** 2017-09
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02535611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02535611, "Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02535611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*